Last reviewed · How we verify
Selexipag Film Coated Tablets
Selexipag Film Coated Tablets is a Small molecule drug developed by Humanis Saglık Anonim Sirketi. It is currently in Phase 1 development.
At a glance
| Generic name | Selexipag Film Coated Tablets |
|---|---|
| Sponsor | Humanis Saglık Anonim Sirketi |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
- Headache
- Diarrhoea
- Nausea
- Pain in Jaw
- Vomiting
- Arthralgia
- Pain in Extremity
- Dizziness
- Dyspepsia
- Upper Respiratory Tract Infection
- Myalgia
- Fatigue
Key clinical trials
- A Clinical Study of to Confirm the Doses of Selexipag in Children With Pulmonary Arterial Hypertension (PHASE2)
- A Clinical Study to Assess the Effect of Clopidogrel on the Pharmacokinetics of Selexipag and Its Active Metabolite in Healthy Male Subjects (PHASE1)
- Bioequivalence Study to Compare Selexipag 400mcg Film Coated Tablets (400 mcg Selexipag) Versus Uptravi® 400mcg Film Coated Tablets (400 mcg Selexipag) (PHASE1)
- Effect of Selexipag on Daily Life Physical Activity of Patients With Pulmonary Arterial Hypertension. (PHASE4)
- A Clinical Study to Investigate the Effect of Gemfibrozil or Rifampicin on Blood Concentrations of Selexipag in Healthy Subjects (PHASE1)
- Comparison of Two Dose Strengths of Selexipag in Healthy Adults (PHASE1)
- Study in Healthy Male Subjects to Demonstrate Bioequivalence of 1600 μg Selexipag Administered as Eight Tablets of 200 μg or as Single Tablet of 1600 μg (PHASE1)
- Effects of Selexipag in Adults With Raynaud's Phenomenon Secondary to Systemic Sclerosis (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Selexipag Film Coated Tablets CI brief — competitive landscape report
- Selexipag Film Coated Tablets updates RSS · CI watch RSS
- Humanis Saglık Anonim Sirketi portfolio CI
Frequently asked questions about Selexipag Film Coated Tablets
What is Selexipag Film Coated Tablets?
Selexipag Film Coated Tablets is a Small molecule drug developed by Humanis Saglık Anonim Sirketi.
Who makes Selexipag Film Coated Tablets?
Selexipag Film Coated Tablets is developed by Humanis Saglık Anonim Sirketi (see full Humanis Saglık Anonim Sirketi pipeline at /company/humanis-sagl-k-anonim-sirketi).
What development phase is Selexipag Film Coated Tablets in?
Selexipag Film Coated Tablets is in Phase 1.
What are the side effects of Selexipag Film Coated Tablets?
Common side effects of Selexipag Film Coated Tablets include Headache, Diarrhoea, Nausea, Pain in Jaw, Vomiting, Arthralgia.